Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasey L Rivas

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.
Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.
Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Pageof 2